Nature Communications (Jun 2016)

The genetic regulatory signature of type 2 diabetes in human skeletal muscle

  • Laura J. Scott,
  • Michael R. Erdos,
  • Jeroen R. Huyghe,
  • Ryan P. Welch,
  • Andrew T. Beck,
  • Brooke N. Wolford,
  • Peter S. Chines,
  • John P. Didion,
  • Narisu Narisu,
  • Heather M. Stringham,
  • D. Leland Taylor,
  • Anne U. Jackson,
  • Swarooparani Vadlamudi,
  • Lori L. Bonnycastle,
  • Leena Kinnunen,
  • Jouko Saramies,
  • Jouko Sundvall,
  • Ricardo D'Oliveira Albanus,
  • Anna Kiseleva,
  • John Hensley,
  • Gregory E. Crawford,
  • Hui Jiang,
  • Xiaoquan Wen,
  • Richard M. Watanabe,
  • Timo A. Lakka,
  • Karen L. Mohlke,
  • Markku Laakso,
  • Jaakko Tuomilehto,
  • Heikki A. Koistinen,
  • Michael Boehnke,
  • Francis S. Collins,
  • Stephen C. J. Parker

DOI
https://doi.org/10.1038/ncomms11764
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 12

Abstract

Read online

More than 90% of genetic variants associated with type 2 diabetes occur in non-coding regions. Scott et al. report genomes, epigenomes and transcriptomes of skeletal muscle from 271 participants with a range of glucose tolerances, revealing a genetic regulatory architecture enriched in muscle stretch/super enhancers.